Oxidative DNA Damage and Arterial Hypertension in Light of Current ESC Guidelines
International Journal of Molecular Sciences · 22.11.2024 · 25 (23) · 12557
DOI: 10.3390/ijms252312557 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.11.2024. Verfasst von Radka Hazuková und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I-Cardiology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, 77900 Ol…. Hauptthemen laut MEDLINE: DNA Damage, Oxidative Stress, Hypertension. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Czech Republic - conceptual development of research organization, Supported by Ministry of Health, Czech Republic - DRO, Ministry of Health, Czech Republic—Conceptual Development of Research Organization.
Abstract (Originalsprache)
A new insight into oxidative stress is based on oxidative deoxyribonucleic acid (DNA) damage. DNA is the pivotal biopolymer for life and health. Arterial hypertension (HT) is a globally common disease and a major risk factor for numerous cardiovascular (CV) conditions and non-cardiac complications, making it a significant health and socio-economic problem. The aetiology of HT is multifactorial. Oxidative stress is the main driver. Oxidative DNA damage (oxidised guanosine (8OHdG), strand breaks (SSBs, DSBs)) seems to be the crucial and initiating causal molecular mechanism leading to HT, acting through oxidative stress and the resulting consequences (inflammation, fibrosis, vascular remodelling, stiffness, thickness, and endothelial dysfunction). In light of the current European Society of Cardiology (ESC) guidelines with defined gaps in the evidence, this manuscript, for the first time, (1) summarizes evidence for oxidative DNA damage in HT and other CV risk factors, (2) incorporates them into the context of known mechanisms in HT genesis, (3) proposes the existing concept of HT genesis innovatively supplemented with oxidative DNA damage, and (4) mentions consequences such as promising new targets for the treatment of HT (DNA damage response (DDR) pathways).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine I-Cardiology, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, 77900 Olomouc, Czech Republic.
- Department of Cardiology and Internal Medicine, Profi-Kardio, s.r.o., 50801 Hořice, Czech Republic.
- IIIrd Department of Internal Medicine-Gerontology and Metabolism, Medical Faculty in Hradec Králové, University Hospital Hradec Králové, Charles University Prague, 50003 Hradec Králové, Czech Republic.
ORCID-Profile: Zdeněk Zadák, Martin Pumprla, Miloš Táborský
Förderung
- Ministry of Health, Czech Republic - conceptual development of research organization
- Supported by Ministry of Health, Czech Republic - DRO
- Ministry of Health, Czech Republic—Conceptual Development of Research Organization
- Ministry of Health, Czech Republic—DRO
Zitieren
APA
Hazuková, R., Zadák, Z., Pleskot, M., Zdráhal, P., Pumprla, M., & Táborský, M. (2024). Oxidative DNA Damage and Arterial Hypertension in Light of Current ESC Guidelines. International Journal of Molecular Sciences, 25(23), 12557. https://doi.org/10.3390/ijms252312557
Vancouver
Hazuková R, Zadák Z, Pleskot M, Zdráhal P, Pumprla M, Táborský M. Oxidative DNA Damage and Arterial Hypertension in Light of Current ESC Guidelines. International Journal of Molecular Sciences. 2024;25(23):12557. doi:10.3390/ijms252312557
BibTeX
@article{Hazukov2024,
author = {Hazuková, Radka and Zadák, Zdeněk and Pleskot, Miloslav and Zdráhal, Petr and Pumprla, Martin and Táborský, Miloš},
title = {Oxidative DNA Damage and Arterial Hypertension in Light of Current ESC Guidelines},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {23},
pages = {12557},
doi = {10.3390/ijms252312557}
}
EUVIMED